Biotechnology Policies and Laws in India: Rules, Guidelines and Institutional Mechanisms

India has built a multi-layered regulatory and legislative framework to govern biotechnology research, safety, commercial applications, and biological resources. The foundation of genetic engineering regulation in India rests on the Environment (Protection) Act, 1986, and its subordinate rules notified in 1989. The regulatory framework oversees research from initial laboratory testing to field trials and commercial production. Policy initiatives like the BioE3 Policy and National Biotechnology Development Strategy expand the focus from basic regulation to high-performance biomanufacturing, innovation, and environmental sustainability.

Legislative Framework Governing Biotechnology

India uses several primary acts and orders to regulate different components of biotechnology, including modified organisms, bio-resources, food safety, and imports.

• Environment (Protection) Act, 1986: Acts as the umbrella law for biosafety regulations across the country.
• Rules 1989: Formally titled “Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989”, these rules were notified under the Environment (Protection) Act, 1986. They govern research, large-scale handling, environmental release, and commercial use of genetically engineered organisms.
• Biological Diversity Act, 2002: Regulates access to biological resources and ensures fair sharing of benefits arising from their commercial use. It operates through a three-tier system: National Biodiversity Authority (NBA) at the central level, State Biodiversity Boards (SBBs) at the state level, and Biodiversity Management Committees (BMCs) at the local body level.
• Food Safety and Standards Act, 2006: Mandates the Food Safety and Standards Authority of India (FSSAI) to regulate manufactured, imported, or sold genetically modified food items.
• Plant Quarantine (Regulation of Import into India) Order, 2003: Regulates the import of transgenic plant material and germplasm for research under the Ministry of Agriculture and Farmers Welfare.

Institutional Mechanism under Rules 1989

Rules 1989 sets up six competent authorities across central, state, and institutional levels to ensure safety during research and deployment.

Regulatory Guidelines for Genome Editing

In 2022, the Ministry of Environment, Forest and Climate Change notified updated guidelines for gene-edited plants to streamline research processes.

Categories of Genome Editing

• Site-Directed Nuclease-1 (SDN-1): Involves small insertions or deletions without introducing foreign DNA. Exempted from GEAC approval and evaluated by IBSC and RCGM.
• Site-Directed Nuclease-2 (SDN-2): Involves small edits using a template DNA without foreign DNA integration. Exempted from GEAC approval and processed through IBSC and RCGM.
• Site-Directed Nuclease-3 (SDN-3): Involves insertion of large foreign genes. Requires GEAC regulatory clearance like traditional Genetically Modified Organisms.

Key Policy Initiatives and Schemes

The Indian government periodically updates national strategies to align biotechnology with economic and environmental targets.

• BioE3 Policy: Approved in August 2024, BioE3 stands for Biotechnology for Economy, Environment, and Employment. It focuses on high-performance biomanufacturing and biofoundries. The policy targets six sectors: Bio-based Chemicals and Enzymes, Functional Food and Smart Proteins, Precision Biotherapeutics, Climate Resilient Agriculture, Biofuels and Carbon Capture, and Futuristic Marine and Space Research.
• Bio-RIDE Scheme: The Biotechnology Research Innovation and Entrepreneurship Development scheme consolidates DBT programs into a unified framework to link academic research with industry.
• National Biotechnology Development Strategy: Focuses on making India a global bio-manufacturing hub and building a $300 billion bioeconomy by 2030.
• BIRAC Support: Biotechnology Industry Research Assistance Council (BIRAC) provides funding through schemes like Biotechnology Ignition Grant (BIG) to support early-stage startups.

Key Facts Summary

• Apex Body for Commercial GMOs: GEAC under MoEFCC gives final clearance for commercial release of genetically engineered crops and products.
• First Commercial GM Crop: Bt Cotton is the only commercially approved GM crop in India, cleared by GEAC in 2002.
• Biosafety Protocol: India ratified the Cartagena Protocol on Biosafety in 2003, which governs transboundary movement of Living Modified Organisms (LMOs).
• Gene Editing Exemptions: SDN-1 and SDN-2 categories of genome editing do not require GEAC approval under current regulatory provisions.
• Six Competent Authorities: Rules 1989 establishes RDAC, IBSC, RCGM, GEAC, SBCC, and DLC to manage biosafety.
• BioE3 Policy: Launched in August 2024 to set up Bio-AI hubs, biofoundries, and circular biomanufacturing models.
• Bioeconomy Target: National policies aim to reach a $300 billion Indian bioeconomy by 2030.